Cairo - Mubasher: MEVAC For Vaccines aims to inject EGP 1.8 billion in new investments into the establishment of three veterinary and human vaccine factories over the coming three years, the CEO Magdy El-Sayed said. 

The company also plans to build a 100-feddan farm for the production of eggs to be used in manufacturing vaccines, El-Sayed added in a statement on Wednesday. 

This came during a meeting between the Executive Director of the General Authority for Investment and Free Zones (GAFI), Mohamed Abdel Wahab, and the CEO of Kemin, Chris Nelson.

The US-based Kemin is a majority shareholder of MEVAC and has more than 22 factories in several countries.